3D Printers

Fluicell introduces high resolution 3D bioprinter, the Biopixlar

Fluicell, a medical technology company spun out from the Chalmers University of Technology, Sweden has launched a high-resolution 3D bioprinter called Biopixlar. This system is an all-in-one discovery platform designed to build novel tissue models for drug development, as well as disease and regenerative medicine research.

Fluicell biotechnology

Founded in 2012, Fluicell develops platforms for cell behavior investigation. Prior to the release of the Biopixlar 3D printer, the company released its BioPen, reportedly the first single-cell lab-on-a-tip tool for targeting individual cells in vitro. An ion channel screening platform named the Dynaflow Resolve system was also produced by Fluicell.

As its latest platform, the Biopixlar enables printing of multiple different cell types in one run with high precision and resolution. The 80cm (H) x 70cm (W) x57cm (D) system includes a micromanipulator arm and a motorized stage to precisely position its printer head and sample.

A unique feature of the Biopixlar is its gamepad interface. This allows for handheld control to position the printer head and deposit cells. Furthermore, an onboard multi-color fluorescence imaging setup allows real-time monitoring of the printing process and post-print analysis.

Fluicell's Biopixlar 3D bioprinter. Photo via Fluicell.
Fluicell’s Biopixlar 3D bioprinter. Photo via Fluicell.

Biopixlar technical specifications 

The production of tissues and disease models can complement and decrease animal testing in the intermediate phases of drug development, causing lower development costs and fewer ethical issues. Such models also accelerate the development of personalized medicine with the use of patient-specific cells. According to Fluicell, Biopixlar offers the optimal resolution for medical research models.

The price for the Biopixlar has yet to be disclosed.

Printing Technology Microfluidic hydrodynamic confined flow technology
Printing Dimension 2D and 3D printing
Printing Mode Direct printing of cell suspension without the need for gel matrix
Printing Surface Cell dish with culture medium or buffer
Deposition Mode From individual to thousands of cells
Microfluidic Printer head Exchangeable single-use consumable made from a medical-grade elastomer. Each has the capacity to hold up to 3 cell wells.
Camera 3 Mpx high sensitivity 1920 x 1080
Slide Holders For 35 mm ø cell dish
For 50 mm ø cell dish
For microtiter plate (6 wells)
Movement Precision 2 micrometers
Software Java – cross-platform compatible
Control Interface Gamepad

 

A 3D tissue model printed with skin cancer cells as a base line ( purple), epithelial cells as a middle layer (red) and skin cancer cells as a top layer (green). Photo via Fluicell.
A 3D tissue model printed with skin cancer cells as a base line ( purple), epithelial cells as a middle layer (red) and skin cancer cells as a top layer (green). Photo via Fluicell.

Subscribe to the 3D Printing Industry newsletter, like us on Facebook and follow us on Twitter for all the latest 3D bioprinting news. Visit 3D Printing Jobs for new opportunities in additive manufacturing.

Featured image shows Fluicell’s Biopixlar 3D bioprinter. Photo via Fluicell.